# Terpenes Explained: The Real Science Behind Cannabis Effects #shorts > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/terpenes-explained-the-real-science-behind-cannabis-effects-shorts/ > **Published:** 2026-09-06T12:14:46-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:29-04:00 > **Clinical Summary:** Explore the role of terpenes in cannabis effects through the entourage effect, challenging traditional strain classifications for personalized therapy. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepNeurologyMental HealthDosingResearchSafetyPolicy Why This Matters This article matters for clinicians and their patients as it highlights the significant role of terpenes in cannabis, which can influence its effects beyond just THC and CBD. Understanding the ‘entourage effect’ can help healthcare providers better tailor treatments to individual patient needs, moving beyond traditional ‘sativa’ vs ‘indica’ classifications. This knowledge can potentially improve symptom management and overall patient care in cannabis therapy. Clinical Summary This article discusses the role of terpenes in cannabis, a lesser-known yet significant component that contributes to its effects. The entourage effect refers to the synergistic interaction between cannabinoids and terpenes, suggesting that the traditional ‘sativa’ vs ‘indica’ categorization may be oversimplified. Clinicians should consider understanding terpene profiles when assessing potential therapeutic benefits for their patients. Dr. Caplan’s Take “As a seasoned family physician specializing in cannabis medicine, I find the latest research on terpenes intriguing. While we must acknowledge that our understanding is still evolving, the potential for these compounds to influence the therapeutic effects of cannabis warrants careful attention and further investigation.” Clinical Perspective 🔬 Embracing the complexity of cannabis, healthcare providers should recognize the significant role of terpenes in modulating its effects beyond THC and CBD. The ‘entourage effect’ suggests that these aromatic compounds, found in varying quantities across different strains, can influence the psychoactive and therapeutic properties of cannabis. However, it’s crucial to acknowledge that the classification of strains as ‘sativa’ or ‘indica’ may oversimplify their effects due to the inconsistent terpene profiles among these labels. In clinical practice, this understanding highlights the importance of individualized patient care, considering not only THC and CBD content but also the specific terpene composition when recommending cannabis for therapeutic purposes. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/sleep/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Terpenes%20Explained%3A%20The%20Real%20Science%20Behind%20Cannabis%20Effects%20%23shorts%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90812)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90812)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Terpenes%20Explained%3A%20The%20Real%20Science%20Behind%20Cannabis%20Effects%20%23shorts%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90812)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [THC vs CBD vs CBG vs CBN vs THCV: The Real Differences Explained](https://cedclinic.com/cbd-vs-thc-vs-cbg-vs-cbn-vs-thcv-differences/) - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 239 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-digest-march-17-2026/) 📰 Source: [https://www.youtube.com/shorts/LOdcbNcQqO8](https://www.youtube.com/shorts/LOdcbNcQqO8) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).